Jinliang Wang

Jinliang Wang

Auto-generated profile, based on publicly available information

Jinliang Wang

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SWShipo Wu
Shipo Wu
GZGongxun Zhong
Gongxun Zhong
JZJUN ZHANG
JUN ZHANG
LSLei Shuai
Lei Shuai
ZZZhang Zhang
Zhang Zhang
WCWei Chen
Wei Chen
The unprecedented coronavirus disease 2019 (COVID-19) epidemic has created a worldwide public health emergency, and there is an urgent need to develop an effective vaccine to control this severe infectious disease. Here, we find that a single vaccination with a replication-defective human type 5 adenovirus encoding the SARS-CoV-2 spike protein (Ad5-nCoV) protect mice completely against mouse-adapted SARS-CoV-2 infection in the upper and lower respiratory tracts. Additionally, a single vaccination with Ad5-nCoV protects ferrets from wild-type SARS-CoV-2 infection in the upper respiratory tract. This study suggests that the mucosal vaccination may provide a desirable protective efficacy and this delivery mode is worth further investigation in human clinical trials.

20 July 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JWJinliang Wang
Jinliang Wang
ZWZilong Wang
Zilong Wang
RLRenqiang Liu
Renqiang Liu
LSLei Shuai
Lei Shuai
XWXinxin Wang
Xinxin Wang
ZBZhigao Bu
Zhigao Bu
Rabies virus (RABV) invades the central nervous system and nearly always causes fatal disease in humans. How RABV interacts with host neuron membrane receptors to become internalized and cause rabid symptoms is not yet fully understood. Here, we identified a novel receptor of RABV, which RABV uses to infect neurons. We found that metabotropic glutamate receptor subtype 2 (mGluR2), a member of the G protein-coupled receptor family that is abundant in the central nervous system, directly interacts with RABV glycoprotein to mediate virus entry. RABV infection was drastically decreased after mGluR2 siRNA knock-down in cells. Antibodies to mGluR2 blocked RABV infection in cells in vitro. Moreover, mGluR2 ectodomain soluble protein neutralized the infectivity of RABV cell-adapted strains and a street strain in cells (in vitro) and in mice (in vivo). We further found that RABV and mGluR2 are internalized into cells and transported to early and late endosomes together. These results suggest that mGluR2 is a functional cellular entry receptor for RABV. Our findings may open a door to explore and understand the neuropathogenesis of rabies. Rabies virus (RABV) invades the central nervous system and nearly always causes fatal disease in humans. How RABV interacts with host neuron membrane receptors to become internalized and cause rabid symptoms is not yet fully understood. Here, we identified metabotropic glutamate receptor subtype 2 (mGluR2) as a novel cellular RABV receptor for host cell entry. mGluR2 directly interacts with RABV G protein and both proteins are internalized together. Our findings may open a door to explore the fundamental molecular mechanisms for rabies neuropathogenesis.

4 August 2020 in Protein & Cell
Verified
Journal Article
Open access
PDF file
JWJinliang Wang
Jinliang Wang
LSLei Shuai
Lei Shuai
CWChong Wang
Chong Wang
RLRenqiang Liu
Renqiang Liu
XHXijun He
Xijun He
ZBZhigao Bu
Zhigao Bu

7 June 2024 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
ZNZixin Ni
Zixin Ni
JWJinliang Wang
Jinliang Wang
XYXiaofei Yu
Xiaofei Yu
YWYifan Wang
Yifan Wang
JWJingfei Wang
Jingfei Wang
ZBZhigao Bu
Zhigao Bu
Influenza virus infection is initiated by the attachment of the viral haemagglutinin (HA) protein to sialic acid receptors on the host cell surface. Most virus particles enter cells through clathrin-mediated endocytosis (CME). However, it is unclear how viral binding signals are transmitted through the plasma membrane triggering CME. Here we found that metabotropic glutamate receptor subtype 2 (mGluR2) and potassium calcium-activated channel subfamily M alpha 1 (KCa1.1) are involved in the initiation and completion of CME of influenza virus using an siRNA screen approach. Influenza virus HA directly interacted with mGluR2 and used it as an endocytic receptor to initiate CME. mGluR2 interacted and activated KCa1.1, leading to polymerization of F-actin, maturation of clathrin-coated pits and completion of the CME of influenza virus. Importantly, mGluR2-knockout mice were significantly more resistant to different influenza subtypes than the wild type. Therefore, blocking HA and mGluR2 interaction could be a promising host-directed antiviral strategy.

30 December 2019 in Viruses
Verified
Journal Article
Open access
PDF file
CWChong Wang
Chong Wang
JWJinliang Wang
Jinliang Wang
LSLei Shuai
Lei Shuai
XMXiao Ma
Xiao Ma
HZHailin Zhang
Hailin Zhang
ZBZhigao Bu
Zhigao Bu
Rabies virus (RABV) invades the central nervous system and nearly always causes fatal disease in humans. RABV enters cells via clathrin-mediated endocytosis upon receptor binding. The detailed mechanism of this process and how it is regulated are not fully understood. Here, we carried out a high-through-put RNAi analysis and identified AP2-associated kinase 1 (AAK1), a serine/threonine kinase, as an important cellular component in regulating the entry of RABV. AAK1 knock-down greatly inhibits RABV infection of cells, and AAK1-induced phosphorylation of threonine 156 of the μ subunit of adaptor protein 2 (AP2M1) is found to be required for RABV entry. Inhibition of AAK1 kinase activity by sunitinib blocked AP2M1 phosphorylation, significantly inhibiting RABV infection and preventing RABV from entering early endosomes. In vivo studies revealed that sunitinib prolongs the survival of mice challenged with RABV street virus. Our findings indicate that AAK1 is a potential drug target for postexposure prophylaxis against rabies.

28 February 2023 in Journal of Virology
Verified
Journal Article
Open access
XWXinxin Wang
Xinxin Wang
ZWZhiyuan Wen
Zhiyuan Wen
HCHuizhen Cao
Huizhen Cao
JLJie Luo
Jie Luo
LSLei Shuai
Lei Shuai
JWJinliang Wang
Jinliang Wang
For most viruses, cell entry involves engagement with many distinct plasma membrane components, each of which is essential. After binding to its specific receptor(s), rabies virus (RABV) enters host cells through the process of clathrin-mediated endocytosis.